Toll-like receptor 4 in butylated hydroxytoluene-induced mouse pulmonary inflammation and tumorigenesis.

Because chronic pulmonary diseases predispose to lung neoplasia, the identification of the molecular mechanisms involved could provide novel preventive, diagnostic, and therapeutic strategies. Toll-like receptors (TLRs) transduce exogenous and endogenous signals into the production of inflammatory cytokines to coordinate adaptive immune responses. To determine the role of Tlr4 in chronic lung inflammation, we compared lung permeability, leukocyte infiltration, and nuclear factor kappa B (NFkappaB) and activator protein 1 (AP-1) DNA binding in butylated hydroxytoluene (BHT)-treated (four weekly injections of 125-200 mg/kg each) inbred mouse strains with functional Tlr4 (OuJ and BALB) and mutated Tlr4 (HeJ and BALB(Lps-d)). We also measured primary tumor formation in these mice after single-carcinogen injection (3-methylcholanthrene; 10 microg/kg), followed by BHT treatment (six weekly injections of 125-200 mg/kg each). Mice with functional Tlr4 had reduced lung permeability, leukocyte inflammation, and primary tumor formation (BALB(Lps-d), mean = 22.3 tumors/mouse, versus BALB, mean = 13.9 tumors/mouse, difference = 8.4 tumors/mouse, 95% confidence interval = 4.6 to 12.1 tumors/mouse; P = .025) compared with mice with mutated Tlr4. NFkappaB DNA binding activity was higher in OuJ than in HeJ mice; however, AP-1 activity was elevated in HeJ mice. To our knowledge, this is the first model to demonstrate a modulatory role for Tlr4 in chronic lung inflammation and tumorigenesis.

[1]  H. Grönberg,et al.  Sequence variants of toll-like receptor 4 are associated with prostate cancer risk: results from the CAncer Prostate in Sweden Study. , 2004, Cancer research.

[2]  N. Shime,et al.  TLR4 signaling is essential for survival in acute lung injury induced by virulent Pseudomonas aeruginosa secreting type III secretory toxins , 2004, Respiratory research.

[3]  T. van der Poll,et al.  Role ofToll-Like Receptor 4 in Gram-Positive and Gram-Negative Pneumonia inMice , 2004, Infection and Immunity.

[4]  Y. Kaneda,et al.  TNF combined with IFN-α accelerates NF-κB-mediated apoptosis through enhancement of Fas expression in colon cancer cells , 2003, Cell Death and Differentiation.

[5]  Mitsunobu Sato,et al.  Toll-like receptor signaling in anti-cancer immunity. , 2003, The journal of medical investigation : JMI.

[6]  Alicia Samuels,et al.  Cancer Statistics, 2003 , 2003, CA: a cancer journal for clinicians.

[7]  C. Cross,et al.  Lung Tumor Development in Mice Exposed to Tobacco Smoke and Fed β-Carotene Diets , 2002 .

[8]  L. Dwyer-Nield,et al.  The lung tumor promoter, butylated hydroxytoluene (BHT), causes chronic inflammation in promotion-sensitive BALB/cByJ mice but not in promotion-resistant CXB4 mice. , 2001, Toxicology.

[9]  S. Akira,et al.  Toll-like receptors control activation of adaptive immune responses , 2001, Nature Immunology.

[10]  L. Dwyer-Nield,et al.  Butylated hydroxytoluene (BHT) induction of pulmonary inflammation: a role in tumor promotion. , 2001, Experimental lung research.

[11]  Hye-Youn Cho,et al.  Ozone-induced lung inflammation and hyperreactivity are mediated via tumor necrosis factor-alpha receptors. , 2001, American journal of physiology. Lung cellular and molecular physiology.

[12]  A. Malkinson,et al.  Compensatory lung growth after partial pneumonectomy enhances lung tumorigenesis induced by 3-methylcholanthrene. , 1999, Cancer research.

[13]  S. Mayne,et al.  Previous lung disease and risk of lung cancer among men and women nonsmokers. , 1999, American journal of epidemiology.

[14]  P. Ricciardi-Castagnoli,et al.  Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. , 1998, Science.

[15]  A. Malkinson.  Molecular comparison of human and mouse pulmonary adenocarcinomas. , 1998, Experimental lung research.

[16]  K. Svenson,et al.  Additional evidence that the K-ras protooncogene is a candidate for the major mouse pulmonary adenoma susceptibility (Pas-1) gene. , 1998, Experimental lung research.

[17]  A. Malkinson,et al.  Butylated hydroxytoluene exposure is necessary to induce lung tumors in BALB mice treated with 3-methylcholanthrene. , 1997, Cancer research.

[18]  M. Potter,et al.  Construction of a BALB/c congenic mouse, C.C3H-Lpsd, that expresses the Lpsd allele: analysis of chromosome 4 markers surrounding the Lps gene , 1994, Infection and immunity.

[19]  A. Malkinson,et al.  The intronic structure of cancer‐related genes regulates susceptibility to cancer , 1994, Molecular carcinogenesis.

[20]  A. Malkinson,et al.  Strain-related differences in the pneumotoxic effects of chronically administered butylated hydroxytoluene on protein kinase C and calpain. , 1994, Toxicology.

[21]  E. Pukkala,et al.  Cancer incidence among 78,000 asthmatic patients. , 1993, International journal of epidemiology.

[22]  Marshall W. Anderson,et al.  Parental bias of Ki-ras oncogenes detected in lung tumors from mouse hybrids. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[23]  A. Malkinson.  The genetic basis of susceptibility to lung tumors in mice. , 1989, Toxicology.

[24]  S. Permutt,et al.  A COMMON FAMILIAL COMPONENT IN LUNG CANCER AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE , 1977, The Lancet.

[25]  H. Witschi,et al.  Enhancement of urethan tumorigenesis in mouse lung by butylated hydroxytoluene. , 1977, Journal of the National Cancer Institute.